Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2466404014 | Loperamide hydrochloride 2mg/simethicone 125mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2472600012 | Loperamide hydrochloride 2mg/simethicone 125mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3468242014 | Product containing loperamide hydrochloride 2 mg and simethicone 125 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3468243016 | Product containing loperamide hydrochloride 2 mg and simeticone 125 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3486811011 | Product containing loperamide hydrochloride 2 mg and simeticone 125 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3501973012 | Loperamide hydrochloride 2 mg and simeticone 125 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3501974018 | Loperamide hydrochloride 2 mg and simethicone 125 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3570037015 | Product containing only loperamide hydrochloride 2 mg and simeticone 125 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3570038013 | Product containing only loperamide hydrochloride 2 mg and simethicone 125 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3570039017 | Product containing only loperamide hydrochloride 2 mg and simeticone 125 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3680329014 | Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3680330016 | Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 105051501000001118 | Loperamide hydrochloride 2mg/simethicone 125mg tablet | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Is a | Loperamide hydrochloride+simethicone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Has active ingredient | Loperamide hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Has active ingredient | Simeticone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Is a | Product containing loperamide and simeticone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Is a | Product containing loperamide in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Has active ingredient | Simeticone | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Has basis of strength substance | Simeticone | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 125 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Has active ingredient | Loperamide hydrochloride | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Has basis of strength substance | Loperamide hydrochloride | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 2 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Has basis of strength substance | Loperamide hydrochloride | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 2 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Has basis of strength substance | Simeticone | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 125 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Has precise active ingredient | Loperamide hydrochloride | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Has precise active ingredient | Simeticone | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Is a | Product containing loperamide and simeticone in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Is a | Product containing only loperamide and simeticone in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Has precise active ingredient | Simeticone | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet | Has precise active ingredient | Loperamide hydrochloride | true | Inferred relationship | Existential restriction modifier | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets